株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界における組織学・細胞学市場の規模、シェア、動向分析:診察タイプ別(、地域別、セグメント予測

Histology and Cytology Market Size, Share & Trends Analysis Report By Type of Examination (Cytology [Cervical Cancer, Breast Cancer], Histology), By Region, And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 515320
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.34円で換算しております。
Back to Top
世界における組織学・細胞学市場の規模、シェア、動向分析:診察タイプ別(、地域別、セグメント予測 Histology and Cytology Market Size, Share & Trends Analysis Report By Type of Examination (Cytology [Cervical Cancer, Breast Cancer], Histology), By Region, And Segment Forecasts, 2019 - 2026
出版日: 2019年03月06日 ページ情報: 英文 100 Pages
概要

当レポートでは、世界の組織学・細胞学市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場直線見通し
  • 市場セグメンテーションと範囲
  • 法規制と償還枠組み
  • 市場動向
    • 市場促進因子分析
    • 市場阻害因子分析
  • 浸透度と成長見通しマッピング
  • PESTLE分析
  • 業界分析
  • 主な取引と戦略的分析
  • 市場参入戦略

第4章 診察タイプ別市場予測と動向分析

  • 動向分析
  • 組織学
  • 細胞学
    • 子宮頸癌
    • 乳癌
    • その他の癌

第5章 地域別予測と動向分析

  • 主要企業リスト:地域別
  • SWOT分析
  • 市場シェア
  • 市場規模と予測、動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合環境

  • 戦略枠組み
  • 戦略マッピング
  • 民間企業リスト
  • 企業プロファイル
図表

List of Tables

  • TABLE 1 List of few research institute
  • TABLE 2 Number of worldwide cancer deaths, 2012
  • TABLE 3 Cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 4 CPT code and description
  • TABLE 5 CPT code and description
  • TABLE 6 North America histology and cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 7 North America histology market, by country, 2015 - 2026 (USD Million)
  • TABLE 8 North America cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 9 North America cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 10 U.S. histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 11 US cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 12 Canada histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 13 Canada cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 14 Europe histology and cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 15 Europe histology market, by country, 2015 - 2026 (USD Million)
  • TABLE 16 Europe cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 17 Europe cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 18 U.K. histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 19 U.K. cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 20 Germany histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 21 Germany cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 22 France histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 23 France cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 24 Italy histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 25 Italy cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 26 Spain histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 27 Spain cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 28 Five Most Common Cancer in Men and Women in Different Regions of Asia:
  • TABLE 29 Asia Pacific histology and cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 30 Asia Pacific histology market, by country, 2015 - 2026 (USD Million)
  • TABLE 31 Asia Pacific cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 32 Asia Pacific cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 33 Japan histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 34 Japan cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 35 China histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 36 China cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 37 Latin America histology and cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 38 Latin America histology market, by country, 2015 - 2026 (USD Million)
  • TABLE 39 Latin America cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 40 Latin America cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 41 Brazil histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 42 Brazil cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 43 Mexico histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 44 Mexico cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 45 Middle East & Africa (MEA) histology market, by country, 2015 - 2026 (USD Million)
  • TABLE 46 Middle East & Africa (MEA) cytology market, by country, 2015 - 2026 (USD Million)
  • TABLE 47 Middle East & Africa cytology market, by application, 2015 - 2026 (USD Million)
  • TABLE 48 South Africa histology and cytology market, by type of examination, 2015 - 2026 (USD Million)
  • TABLE 49 South Africa cytology market, by application, 2015 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market Research Process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain Based Sizing & Forecasting
  • FIG. 6 QFD Modeling For Market Share Assessment
  • FIG. 7 Market Summary, 2018
  • FIG. 8 Market Trends & Outlook
  • FIG. 9 Market Segmentation & Scope
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Penetration & Growth Prospect Mapping
  • FIG. 13 Histology and Cytology Market - PESTLE Analysis
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Histology and Cytology Market: Type of Examination Outlook Key Takeaways
  • FIG. 16 Histology and Cytology Market: Type of Examination Movement Analysis
  • FIG. 17 Global Histology Market, 2015 - 2026 (USD Million)
  • FIG. 18 Global Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 19 Global Cervical Cancer Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 20 Global Breast Cancer Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 21 Global Other Cancer Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 22 Regional Market Place: Key Takeaways
  • FIG. 23 Regional Outlook, 2018 & 2026
  • FIG. 24 North America Histology And Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 25 U.S. Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 26 Canada Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 27 Europe Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 28 U.K. Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 29 Germany Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 30 France Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 31 Italy Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 32 Spain Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 33 Asia Pacific Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 34 Japan Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 35 China Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 36 Latin America Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 37 Brazil Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 38 Mexico Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 39 Middle East & Africa Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 40 South Africa Histology and Cytology Market, 2015 - 2026 (USD Million)
  • FIG. 41 Strategy Framework
  • FIG. 42 Strategy Mapping
  • FIG. 43 Heat Map Analysis
目次
Product Code: GVR-1-68038-917-3

The global histology and cytology market size is expected to reach USD 30.6 billion by 2026, based on a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 13.7% during the forecast period. Increasing incidence of cancer coupled with growing adoption of cytological test due to its high reliability and less invasive nature as compared to biopsy is likely to drive the growth.

Furthermore, rising number of well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to positively affect market growth. Advancements in cytology and histology save the time for pathologists, making the service more cost-effective.

Technological advancements and launch of new products are the high impact rendering drivers for the histology and cytology market. In March 2018, Roche launched VENTANA DP 200 slide scanner. It is a high-speed slide scanner for digital pathology. The scanner reduces workflow errors and improves image quality. In March 2016, Becton, Dickinson and Company received approval from the U.S. FDA for its automated cervical cancer screening systems, namely BD Totalys MultiProcessor and BD Totalys SlidePrep. These instruments are used for gynecological specimen preparation.

In February 2014, Roche launched a new test for cervical cancer screening, Automated CINtec PLUS cytology test, which improves detection of cervical precancer. In March 2018, BD Life Sciences-Diagnostic Systems launched BD SurePath, a liquid-based cytology test in India for screening and detection of cervical cancer, precancerous lesions, and other cytological categories.

Further key findings from the study suggest:

  • Cytology testing led the market in 2018, attributed to high disease prevalence and adoption of the test for cervix screening. The segment is expected to maintain its position during the forecast period due to the recent entry of various tests and advantages over histology such as faster analysis and cost-effectiveness
  • The U.S. histology and cytology market was the largest in 2018 and is expected to maintain its dominance during the forecast period due to higher awareness about screening and higher healthcare expenditure as compared to the developing countries
  • Asia Pacific is projected to witness substantial growth over the next decade owing to growing investment by several clinics in the region, growing healthcare expenditure, and adoption of screening tests

Some of the key players operating in the market are: Abbott Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; and Trivitron Healthcare.

Table of Content

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Segmentation and Scope
  • 3.3 Regulatory and Reimbursement Framework
  • 3.4 Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Rising incidence of Cancer
      • 3.4.1.2 Technological developments
      • 3.4.1.3 Increasing number of awareness programs for cervical cancer screening
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Low sensitivity of cytology tests
      • 3.4.2.2 Conditions required for specimens and problem of mislabeled specimens
  • 3.5 Penetration & Growth Prospects Mapping
  • 3.6 Histology and Cytology Market - PESTLE Analysis
    • 3.6.1 Political landscape
    • 3.6.2 Environmental landscape
    • 3.6.3 Social landscape
    • 3.6.4 Technology landscape
    • 3.6.5 Legal landscape
  • 3.7 Industry Analysis - Porter's
    • 3.7.1 Supplier power
    • 3.7.2 Buyer power
    • 3.7.3 Substitution threat
    • 3.7.4 Threat from new entrant
    • 3.7.5 Competitive rivalry
  • 3.8 Major Deals and Strategic Analysis
  • 3.9 Market Entry Strategies

Chapter 4 Histology and Cytology Market: Type of Examination Estimates & Trend Analysis

  • 4.1 Histology and Cytology Market: Type of Examination Movement Analysis
  • 4.2 Histology
    • 4.2.1 Histology market, 2015 - 2026 (USD Million)
  • 4.3 Cytology
    • 4.3.1 Cytology market, 2015 - 2026 (USD Million)
    • 4.3.2 Cervical cancer
      • 4.3.2.1 Cervical cancer cytology market, 2015 - 2026 (USD Million)
    • 4.3.3 Breast cancer
      • 4.3.3.1 Breast cancer cytology market, 2015 - 2026 (USD Million)
    • 4.3.4 Other cancer
      • 4.3.4.1 Other cancer cytology market, 2015 - 2026 (USD Million)

Chapter 5 Histology and Cytology Market: Regional Estimates & Trend Analysis

  • 5.1 List of Players, by Region
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia Pacific
    • 5.3.4 Latin America
    • 5.3.5 Middle East & Africa
  • 5.2 SWOT Analysis, by Region
    • 5.2.1 North America
    • 5.2.2 Europe
    • 5.2.3 Asia Pacific
    • 5.2.4 Latin America
    • 5.2.5 Middle East & Africa
  • 5.3 Histology and Cytology Market Share by Region, 2018 & 2026
  • 5.4. Market Size & Forecasts and Trend Analysis, 2015 to 2026
  • 5.5 North America
    • 5.5.1 North America histology and cytology market, 2015 - 2026 (USD Million)
    • 5.5.2 U.S.
      • 5.5.2.1 U.S. histology and cytology market, 2015 - 2026 (USD Million)
    • 5.5.3 Canada
      • 5.5.3.1 Canada histology and cytology market, 2015 - 2026 (USD Million)
  • 5.6 Europe
    • 5.6.1 Europe histology and cytology market, 2015 - 2026 (USD Million)
    • 5.6.2 U.K.
      • 5.6.2.1 U.K. histology and cytology market, 2015 - 2026 (USD Million)
    • 5.6.3 Germany
      • 5.6.3.1 Germany histology and cytology market, 2015 - 2026 (USD Million)
    • 5.6.4 France
      • 5.6.4.1 France histology and cytology market, 2015 - 2026 (USD Million)
    • 5.6.5 Italy
      • 5.6.5.1 Italy histology and cytology market, 2015 - 2026 (USD Million)
    • 5.6.6 Spain
      • 5.6.6.1 Spain histology and cytology market, 2015 - 2026 (USD Million)
  • 5.7 Asia Pacific
    • 5.7.1 Asia Pacific histology and cytology market, 2015 - 2026 (USD Million)
    • 5.7.2 Japan
      • 5.7.2.1 Japan histology and cytology market, 2015 - 2026 (USD Million)
    • 5.7.3 China
      • 5.7.3.1 China histology and cytology market, 2015 - 2026 (USD Million)
  • 5.8 Latin America
    • 5.8.1 Latin America histology and cytology market, 2015 - 2026 (USD Million)
    • 5.8.2 Brazil
      • 5.8.2.1 Brazil histology and cytology market, 2015 - 2026 (USD Million)
    • 5.8.3 Mexico
      • 5.8.3.1 Mexico histology and cytology market, 2015 - 2026 (USD Million)
  • 5.9 Middle East and Africa
    • 5.9.1 Middle East & Africa histology and cytology market, 2015 - 2026 (USD Million)
    • 5.9.2 South Africa
      • 5.9.2.1 South Africa histology and cytology market, 2015 - 2026 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Strategy Mapping
  • 6.3 Public Companies
    • 6.3.1 Company Market Position Analysis/Heat Map Analysis (Revenue, geographic presence, service portfolio, key serviceable industries, key alliances)
  • 6.4 List of Private Companies
  • 6.5 Company Profiles
    • 6.5.1 Hologic, Inc.
      • 6.5.1.1 Company Overview
      • 6.5.1.2 Financial Performance
      • 6.5.1.3 Product Benchmarking
      • 6.5.1.4 Strategic Initiatives
    • 6.5.2 F. Hoffmann-La Roche Ltd
      • 6.5.2.1 Company Overview
      • 6.5.2.2 Financial Performance
      • 6.5.2.3 Product Benchmarking
      • 6.5.2.4 Strategic Initiatives
    • 6.5.3 Abbott
      • 6.5.3.1 Company Overview
      • 6.5.3.2 Financial Performance
      • 6.5.3.3 Product Benchmarking
      • 6.5.3.4 Strategic Initiatives
    • 6.5.4 Becton, Dickinson & Company
      • 6.5.4.1 Company Overview
      • 6.5.4.2 Financial Performance
      • 6.5.4.3 Product Benchmarking
      • 6.5.4.4 Strategic Initiatives
    • 6.5.5 Danaher
      • 6.5.5.1 Company Overview
      • 6.5.5.2 Financial Performance
      • 6.5.5.3 Product Benchmarking
      • 6.5.5.4 Strategic Initiatives
    • 6.5.6 Merck KGaA
      • 6.5.6.1 Company Overview
      • 6.5.6.2 Financial Performance
      • 6.5.6.3 Product Benchmarking
      • 6.5.6.4 Strategic Initiatives
    • 6.5.7 Thermo Fisher Scientific, Inc.
      • 6.5.7.1 Company Overview
      • 6.5.7.2 Financial Performance
      • 6.5.7.3 Product Benchmarking
      • 6.5.7.4 Strategic Initiatives
    • 6.5.8 Sysmex Corporation
      • 6.5.8.1 Company Overview
      • 6.5.8.2 Financial Performance
      • 6.5.8.3 Product Benchmarking
      • 6.5.8.4 Strategic Initiatives
    • 6.5.9 Trivitron Healthcare
      • 6.5.9.1 Company Overview
      • 6.5.9.2 Product Benchmarking
      • 6.5.9.3 Strategic Initiatives
    • 6.5.10 Koninklijke Philips N.V.
      • 6.5.10.1 Company Overview
      • 6.5.10.2 Financial Performance
      • 6.5.10.3 Product Benchmarking
      • 6.5.10.4 Strategic Initiatives
Back to Top